Open Access
CC-BY-NC-ND 4.0 · J Neurol Surg Rep 2017; 78(01): e34-e36
DOI: 10.1055/s-0037-1598112
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Calcified Middle Cranial Fossa Mass

James Botros
1   Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States
,
Kimmo Hatanpaa
2   Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States
,
Brandon Isaacson
3   Department of Otolaryngology, University of Texas Southwestern Medical Center, Dallas, Texas, United States
,
Samuel L. Barnett
1   Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

20. Juli 2016

21. Dezember 2016

Publikationsdatum:
01. März 2017 (online)

Preview

Abstract

A 21-year-old male presented for evaluation of transient loss of consciousness and was found to have a hyperdense mass in the left middle fossa. He underwent craniotomy for tumor resection. Intra- and extradural invasion was noted. Gross total resection was achieved. Pathology demonstrated a densely cellular neoplasm with predominately spindle cell morphology in a collagen-containing stroma, areas of vascular proliferation, focal mineralization, and regions of cartilage formation. High mitotic index and regions of necrosis were seen. Based on the final diagnosis of osteosarcoma, the patient was referred for chemotherapy and radiation. Intracranial osteosarcoma is a nonmeningiomatous mesenchymal tumor. Most osteosarcomas are meningeal-based and supratentorial. Presentation depends on tumor location and may include focal neurologic deficits, cranial neuropathy, seizures, or symptoms of increased intracranial pressure. Given the relative rarity of intracranial osteosarcoma, there are no established guidelines for treatment, and therapy is guided by experience with systemic osteosarcoma. Gross total resection is recommended whenever feasible. Both chemotherapy and radiation therapy are used as adjuvant therapy. Regardless of treatment, osteosarcoma remains a highly aggressive malignancy with a poor prognosis. Morbidity and mortality may be the result of local recurrence or development of pulmonary or skeletal metastasis.